The results showed that most of the TGF-β pathway genes were risk factors in other types of tumors, but were protective factors in ccRCC, which was consistent with our previous analysis that the KEGG-TGF-β low-score group had a worse prognosis. The gene discussed is TGFB1; the disease is nonpapillary renal cell carcinoma.